Cerebral Glucose Metabolism Is Decreased in White Matter Changes in Patients with Phenylketonuria

Cerebral magnetic resonance imaging (MRI) has revealed white matter changes in patients with phenylketonuria (PKU), an inborn error of metabolism with increased plasma phenylalanine level. Because the significance of these lesions is unknown, this study was undertaken to determine whether glucose metabolism was depressed in cerebral white matter MRI changes in patients with PKU. Four patients with PKU and nine healthy volunteers with an average age of 23 y (range 19-26 y) and 23 y (range 20-27 y), respectively, were studied. The IQ of patients with PKU was between 58 and 97. Cerebral MRI and positron emission tomography images with 18F-deoxyglucose were obtained, and arteriovenous differences for oxygen and glucose as well as cerebral blood flow was measured simultaneously to determine global cerebral oxygen and glucose metabolism. Cerebral MRI revealed that all patients with PKU had white matter changes with characteristic localization. In patients with PKU, regional glucose metabolism was 36% lower in the anterior periventricular areas, 0.14 ± 0.06 compared with 0.22 ± 0.04μmol·g-1·min-1 in controls (mean ± SD,p < 0.05, Mann-Whitney). Further, the ratio between glucose metabolism in the affected white matter and the cortex was 14% lower in the patients, decreasing from 0.57 ± 0.05 to 0.48 ± 0.06(p < 0.05). Global cerebral blood flow, oxygen and glucose consumption were similar in the two groups. In conclusion, regional glucose metabolism is lower in MRI-demonstrated white matter changes. In mildly intellectually impaired patients with PKU, global cerebral glucose and oxygen metabolism remain intact.

[1]  J D Brodie,et al.  Intersubject variability of brain glucose metabolic measurements in young normal males. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  M. Seashore,et al.  In Vivo Measurement of Phenylalanine in Human Brain by Proton Nuclear Magnetic Resonance Spectroscopy , 1995, Pediatric Research.

[3]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[4]  A. M. Sendyk,et al.  Performance Figures and Images from the Therascan 3128 Positron Emission Tomograph , 1984, IEEE Transactions on Nuclear Science.

[5]  H. Lou LARGE DOSES OF TRYPTOPHAN AND TYROSINE AS POTENTIAL THERAPEUTIC ALTERNATIVE TO DIETARY PHENYLALANINE RESTRICTION IN PHENYLKETONURIA , 1985, The Lancet.

[6]  A. Thompson,et al.  Neurological deterioration in young adults with phenylketonuria , 1990, The Lancet.

[7]  E. Reynolds,et al.  ONE DRUG (PHENYTOIN) IN TREATMENT OF EPILEPSY , 1976, The Lancet.

[8]  R A Brooks,et al.  Alternative formula for glucose utilization using labeled deoxyglucose. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  M. Buchsbaum,et al.  Regional glucose metabolic changes after learning a complex visuospatial/motor task: a positron emission tomographic study , 1992, Brain Research.

[10]  A. Thompson,et al.  Brain MRI changes in phenylketonuria. Associations with dietary status. , 1993, Brain : a journal of neurology.

[11]  H. C. Engell,et al.  Measurement of cerebral blood flow by intravenous xenon-133 technique and a mobile system. Reproducibility using the Obrist model compared to total curve analysis. , 1986, Neurological research.

[12]  O. Paulson,et al.  99mTc-d,l-HMPAO and SPECT of the Brain in Normal Aging , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  P. Hecke,et al.  Localized brain proton NMR spectroscopy in young adult phenylketonuria patients , 1994, Magnetic resonance in medicine.